US Patent 11051497 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
Patent 11051497 was granted and assigned to Kymab on July, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 19, 2014
Date of Patent
July 6, 2021
Patent Applicant
Patent Application Number
14220074
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11051497 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
